INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

8,524 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
DS
Dotan SaarEVP Countries & BD
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$24K
800 sh
Sep 8, 2026Sep 9, 2026
Page 49 of 214
← PrevNext →
traded Sep 8, 2026
+1d
SEC Form 4

Evidence

31
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$458K
5,387 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

30
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$793K
17.9K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$90K
233 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

30
MR
Mehta RajatEVP, GBL Commercial Operations
BIOBIO.BBIO-RAD LABORATORIES, INC.
Tax withholding
F$195K
504 sh
Sep 5, 2026Sep 9, 2026
traded Sep 5, 2026
+4dSEC Form 4

Evidence

30
PD
Phillips DominicSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$518K
11.7K sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC Form 4

Evidence

56
SA
Stamler David AllenDirector, Chief Executive Officer
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

56
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

56
CL
Cheng LawrenceDirector
GMEGameStop Corp.
Open-market purchase
BUY$1.03M
55.0K sh
Sep 8, 2026Sep 8, 2026
traded Sep 8, 2026
+0dSEC Form 4

Evidence

52
MA
Marks Peter AshleyDirector
ATHEALTERITY THERAPEUTICS LTD
Open-market purchase
BUY$24K
47.6K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

51
RW
Roeder Clinton WilliamChief Financial Officer
TISITEAM INC
Open-market purchase
BUY$221K
8,000 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

51
SR
Speth RalfDirector
SHMDSCHMID Group N.V.
Open-market purchase
BUY$114K
35.0K sh
Aug 31, 2026Sep 8, 2026
traded Aug 31, 2026
+8dSEC Form 4

Evidence

48
MJ
Meyer-Gloeckner Birger JohannesDirector
ZIMZIM Integrated Shipping Services Ltd.
Open-market sale
SELL$44K
1,531 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

46
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$1.60M
900.0K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

46
WJ
Wambeke David J.Chief Business Officer
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp
Open-market purchase
BUY$67K
33.3K sh
Aug 27, 2026Sep 8, 2026
traded Aug 27, 2026
+12dSEC Form 4

Evidence

43
SR
Speth RalfDirector
SHMDSCHMID Group N.V.
Open-market purchase
BUY$101K
33.0K sh
Sep 2, 2026Sep 8, 2026
traded Sep 2, 2026
+6dSEC Form 4

Evidence

42
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Open-market purchase
BUY$4.11M
54.3K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

41
BW
Bradford Tonya WilliamsDirector
LOBLive Oak Bancshares, Inc.
Open-market sale
SELL$64K
1,600 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

38
MA
Macdonald AndrewSee Remarks
UBERUber Technologies, Inc
Open-market purchase
BUY$1.20M
15.7K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
MF
Musa FernandoDirector
PCTPureCycle Technologies, Inc.
Open-market purchase
BUY$99K
15.5K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
AL
Agress Adam LEVP Business Development
KTCCKEY TRONIC CORP
Open-market sale
SELL$2,602
1,112 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
CR
Courtney Mark RVice President of Supply Chain
KTCCKEY TRONIC CORP
Open-market sale
SELL$1,324
566 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

36
VG
Voorhees Anthony GeneEVP-Admin, CFO, Treasurer
KTCCKEY TRONIC CORP
Open-market sale
SELL$3,283
1,403 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

34
LT
Lantheus Alpha Therapy, LLC10% Owner
CATXPerspective Therapeutics, Inc.
Open-market sale
SELL$251K
80.8K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

33
GL
Gehring Rob L.CEO, Americas
MNSTMonster Beverage Corp
Tax withholding
F$386K
8,760 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

33
GJ
Grayson Blake JeffreyChief Financial Officer
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$2.10M
30.0K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

32
BD
Berho Carranza DiegoChief Portfolio Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$22K
6,219 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

32
SM
Sever MichalCMO
NYAXNayax Ltd.
Open-market sale
SELL$1,779
34 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

32
MF
McLaughlin Matthew F.Director, Chief Executive Officer
SCORCOMSCORE, INC.
Open-market purchase
BUY$84K
16.6K sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

31
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$255K
9,705 sh
Sep 4, 2026Sep 8, 2026
traded Sep 4, 2026
+4dSEC Form 4

Evidence

31
SR
Speth RalfDirector
SHMDSCHMID Group N.V.
Grant or award
A$96K
16.3K sh
May 23, 2026Sep 8, 2026
traded May 23, 2026
+108dSEC Form 4

Evidence

31
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Open-market sale
SELL$249K
5,666 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

31
PM
Prosor MayaChief Business Officer
LMNDLemonade, Inc.
Open-market sale
SELL$57K
1,040 sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC Form 4

Evidence

56
DA
De Angoitia AlfonsoDirector
LILALiberty Latin America Ltd.
Open-market purchase
BUY$3.06M
145.5K sh
Aug 31, 2026Sep 4, 2026
traded Aug 31, 2026
+4dSEC Form 4

Evidence

52
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$4.90M
100.9K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

50
SB
Spetzler David BaxleyPresident
CAICaris Life Sciences, Inc.
Open-market sale
SELL$9.73M
393.1K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

50
SR
Steiner Jason RobertSEE REMARKS
PFLEXPIMCO Flexible Credit Income Fund
Open-market purchase
BUY$1.01M
148.8K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

48
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$1.31M
27.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

48
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$1.94M
40.4K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

46
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$260K
9,852 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K